NHINYSEReal Estate Investment TrustsFiscal year ends December 31
NATIONAL HEALTH INVESTORS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$64.70−1.58 (-2.38%)
Close on Oct 19, 2026
- Market cap
- $3.14B
- P/E (TTM)
- 18.7
- Dividend yield
- 5.38%
National Health Investors statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Real Estate Investment Trusts companies for comparison
Valuation
| Measure | National Health Investors | Industry median |
|---|---|---|
| Market Cap | $3.18B | $304.72M |
| Enterprise Value | $3.15B | $295.22M |
| PE Ratio | 18.70 | 23.94 |
| PS Ratio | 7.35 | 4.26 |
| PB Ratio | 2.02 | 1.68 |
| P/TBV Ratio | 2.02 | 1.81 |
| P/OCF Ratio | 12.78 | 12.25 |
Enterprise value
| Measure | National Health Investors | Industry median |
|---|---|---|
| EV / Sales | 7.30 | 4.09 |
Income (trailing twelve months)
| Measure | National Health Investors | Industry median |
|---|---|---|
| Revenue | $432.12M | $459.73M |
| Net Income | $166.80M | $5.22M |
| EPS (Diluted) | $3.46 | $0.45 |
Margins
| Measure | National Health Investors | Industry median |
|---|---|---|
| Profit Margin | 38.6% | 9.91% |
Returns
| Measure | National Health Investors | Industry median |
|---|---|---|
| Return on Equity (ROE) | 10.9% | 4.18% |
| Return on Assets (ROA) | 5.89% | 1.79% |
Growth
| Measure | National Health Investors | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 23.9% | 4.38% |
| Net Income Growth (YoY) | 16.7% | 7.47% |
| EPS Growth (YoY) | 10.5% | 8.10% |
| Revenue Growth (3Y CAGR) | 10.5% | 4.18% |
| Revenue Growth (5Y CAGR) | 2.45% | 7.63% |
| EPS Growth (3Y CAGR) | 26.8% | -0.11% |
| EPS Growth (5Y CAGR) | -6.11% | 6.21% |
Balance sheet
| Measure | National Health Investors | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $30.39M | $1.14M |
| Net Cash (Debt) | $30.39M | $859.51K |
| Net Cash Per Share | $0.62 | $0.04 |
| Equity (Book Value) | $1.57B | -$37.14K |
| Book Value Per Share | $32.00 | -$0.00 |
| Tangible Book Value | $1.57B | -$78.08K |
Cash flow (trailing twelve months)
| Measure | National Health Investors | Industry median |
|---|---|---|
| Operating Cash Flow | $248.68M | $15.25M |
Efficiency
| Measure | National Health Investors | Industry median |
|---|---|---|
| Asset Turnover | 0.15 | 0.13 |
| Revenue Per Employee | $13.50M | $2.42M |
| Profits Per Employee | $5.21M | $122.44K |
| Employee Count | 32 | 64 |
Dividends and yields
| Measure | National Health Investors | Industry median |
|---|---|---|
| Earnings Yield | 5.25% | 2.10% |
| Dividend Yield | 5.38% | 5.74% |
| Buyback Yield | -3.24% | 0.13% |
| Shareholder Yield | 2.14% | 5.18% |
| Dividend Per Share | $3.48 | $1.34 |
| Dividend Growth (YoY) | 22.5% | 1.18% |
| Years of Dividend Growth | 1 | 1 |
| Payout Ratio | 105.3% | 122.1% |
Shares
| Measure | National Health Investors | Industry median |
|---|---|---|
| Shares Outstanding | 49,110,400 | 30,666,700 |
| Shares Change (YoY) | 5.73% | 0.69% |
| Shares Change (QoQ) | 0.00% | 0.01% |
| Float | 47,890,900 | 24,340,100 |
| Shares Held by Insiders | 2.48% | 17.6% |
| Shares Held by Institutions | 77.7% | 68.4% |
Scores
| Measure | National Health Investors | Industry median |
|---|---|---|
| Graham Number | $49.91 | $20.69 |
| Graham Upside | -22.9% | -28.7% |
| Altman Z-Score | 2.88 | 6.12 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from National Health Investors's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.